Printer Friendly

Bausch & Lomb Adds Catherine M. Burzik to Board of Directors.

ROCHESTER, N.Y. -- Bausch & Lomb (NYSE:BOL) announced that Catherine M. Burzik, president and chief executive officer of Kinetic Concepts, Inc. (NYSE:KCI) has been elected to its Board of Directors. Ms. Burzik will serve until the next annual meeting of shareholders, when she will be nominated for election to a one-year term by shareholders.

"Cathy Burzik brings to the Bausch & Lomb board a wealth of experience in the management of global medical technology businesses," said Ronald L. Zarrella, chairman and CEO of the company. "Such expertise and perspective will be invaluable as we continue to invest in and develop new healthcare technologies that can drive future growth."

Ms. Burzik joined KCI, a $1.4 billion company headquartered in San Antonio, Texas that develops and markets advanced therapeutic systems designed to improve wound healing and reduce pulmonary and circulatory complications associated with patient immobility, in November 2006.

Before joining KCI, Ms. Burzik served as president of Applied Biosystems, a unit of Applera Corporation. She has also held senior positions at Eastman Kodak and Johnson & Johnson. At Eastman Kodak, her executive positions included CEO and President of Kodak Health Imaging Systems and general manager/vice president of Corporate Marketing. She served on the board of directors at Cordis Corporation, prior to its acquisition by J&J. At J&J she ran the Critikon medical technology business and subsequently was appointed president of J&J's Ortho-Clinical Diagnostics, Inc. unit.

Ms. Burzik, 56, has a BA in mathematics from Canisius College in Buffalo, New York, and a MA in Mathematics from the University of Buffalo. She has also attended executive management programs at Penn State, Northwestern University's Kellogg School of Management and the Center for Creative Leadership. She serves on the board of trustees of Canisius College.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb employs approximately 13,700 people worldwide and its products are available in more than 100 countries. More information about the Company is on the Bausch & Lomb Web site at Copyright Bausch & Lomb Incorporated.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 19, 2007
Previous Article:Southern Wine & Spirits of America, Inc. Strengthens Its Historic Commitment to Professional Excellence in Wine Education and Wine Service.
Next Article:Limbs of Love Donates $250,000 in Artificial Limbs to the Needy.

Related Articles
Luxottica Group to Purchase Bausch & Lomb Sunglass Business.
Bausch & Lomb Responds to Wesley Jessen; Preliminary Proxy Materials To Be Filed Today.
Bausch & Lomb Appoints William H. Waltrip Chief Executive Officer Upon Resignation of William M. Carpenter.
Alan M. Bennett, Chief Financial Officer of Aetna, Joins Bausch & Lomb Board of Directors.
Bausch & Lomb Conducts Annual Meeting of Shareholders and Declares Quarterly Dividend; Four Directors Elected; Dividend of $0.13 Per Share Payable...
Catherine M. Burzik Named CEO of Kinetic Concepts, Inc. (KCI).
Bausch & Lomb Announces Changes in Americas Region Commercial Management.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters